NASDAQ:XGN
Exagen Inc. Stock News
$1.88
-0.0100 (-0.529%)
At Close: May 17, 2024
XGN Stock Price Increases Over 34% Intraday: Why It Happened
01:42pm, Tuesday, 10'th Aug 2021
The stock price of Exagen Inc. (Nasdaq: XGN) increased by over 34% during intraday trading. This is why it happened.
Exagen, Inc. (XGN) CEO Ron Rocca on Q2 2021 Results - Earnings Call Transcript
10:23am, Tuesday, 10'th Aug 2021
Exagen, Inc. (XGN) CEO Ron Rocca on Q2 2021 Results - Earnings Call Transcript
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
07:59pm, Monday, 09'th Aug 2021
Exagen Inc. (XGN) delivered earnings and revenue surprises of 24.00% and 9.79%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Exagen Inc. Reports Second Quarter 2021 Results
04:05pm, Monday, 09'th Aug 2021
Quarterly Records: Total Revenue, AVISE® CTD Revenue and Volumes, Ordering Healthcare Providers and Adopters Quarterly Records: Total Revenue, AVISE® CTD Revenue and Volumes, Ordering Healthcare Pro
Exagen Appoints Ana Hooker to Board of Directors
08:25am, Friday, 30'th Jul 2021
SAN DIEGO, July 30, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional indepen
Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
08:25am, Thursday, 29'th Jul 2021
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 41st Annual Gro
SAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the publication of their latest clinical utility study in
Exagen Elects Frank Stokes to Board of Directors
08:29am, Friday, 18'th Jun 2021
SAN DIEGO, June 18, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the company's stockholders approved the election of Mr.
Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference
04:05pm, Monday, 24'th May 2021
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 41st Annual Growth S
Exagen Inc. (XGN) CEO Ron Rocca on Q1 2021 Results - Earnings Call Transcript
08:57pm, Tuesday, 11'th May 2021
Exagen Inc. (XGN) CEO Ron Rocca on Q1 2021 Results - Earnings Call Transcript
Exagen Inc. Reports First Quarter 2021 Results
04:05pm, Tuesday, 11'th May 2021
Quarterly Records: AVISE® CTD Volumes, Ordering Healthcare Providers and Adopters
The suite of innovative biomarker assays seeks to further aid clinicians in the diagnosis, prognosis and monitoring of patients with autoimmune diseases The suite of innovative biomarker assays seeks
Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
08:25am, Monday, 03'rd May 2021
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of awa
Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021
04:05pm, Tuesday, 27'th Apr 2021
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2021 after
Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases
08:25am, Monday, 29'th Mar 2021
SAN DIEGO, March 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today
